RQHTF (Reliq Health Technologies) 3-Year EBITDA Growth Rate: 0.00% (As of Sep. 2022)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

RQHTF Reliq Health Technologies Inc RQHTF
10 GF Score
Price $0.01
View Full Analysis

What is Reliq Health Technologies 3-Year EBITDA Growth Rate?

Reliq Health Technologies RQHTF -99.99% 10 3-Year EBITDA Growth Rate is 0.00% as of Sep. 2022. GuruFocus rates RQHTF with a GF Score™ of 10/100.

Reliq Health Technologies's EBITDA per Share for the three months ended in Sep. 2022 was $0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Reliq Health Technologies  (OTCPK:RQHTF) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Reliq Health Technologies 3-Year EBITDA Growth Rate Related Terms

RQHTF vs VEEV, GEHC, RCM: 3-Year EBITDA Growth Rate Comparison

For the Health Information Services subindustry, Reliq Health Technologies's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Reliq Health Technologies 3-Year EBITDA Growth Rate vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Reliq Health Technologies's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Reliq Health Technologies's 3-Year EBITDA Growth Rate falls into.


RQHTF
10GF Score
Reliq Health Technologies Inc RQHTF
3-Year EBITDA Growth Rate is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Reliq Health Technologies 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

What does a 3-Year EBITDA Growth Rate of 0.00% mean?
Reliq Health Technologies (RQHTF) has a 3-Year EBITDA Growth Rate of 0.00% as of Sep. 2022. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Reliq Health Technologies and its competitors.
Is Reliq Health Technologies' 3-Year EBITDA Growth Rate too high?
Reliq Health Technologies' current 3-Year EBITDA Growth Rate is 0.00%. Overall, Reliq Health Technologies has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does Reliq Health Technologies' 3-Year EBITDA Growth Rate compare to VEEV and GEHC?
Reliq Health Technologies' 3-Year EBITDA Growth Rate of 0.00% can be compared against companies in the Healthcare Providers & Services industry. The industry median 3-Year EBITDA Growth Rate is 10.20. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Healthcare Providers & Services company?
The median 3-Year EBITDA Growth Rate among Healthcare Providers & Services companies is 10.20, based on 525 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Reliq Health Technologies and its competitors. For the Healthcare Providers & Services industry, the median 3-Year EBITDA Growth Rate is 10.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Reliq Health Technologies's current 3-Year EBITDA Growth Rate is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Reliq Health Technologies stock overvalued right now?
Reliq Health Technologies (RQHTF) has a current 3-Year EBITDA Growth Rate of 0.00%. The current 3-Year EBITDA Growth Rate is 0.00%. Reliq Health Technologies' overall GF Score™ is 10/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Reliq Health Technologies (RQHTF), the current 3-Year EBITDA Growth Rate is 0.00% as of Sep. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Reliq Health Technologies Business Description

Address 175 Longwood Rd S., Suite 406A, Hamilton, ON, CAN, L8P 0A1
Reliq Health Technologies Inc specializes in developing Software-as-a-Service (SaaS) solutions for remote patient monitoring, telemedicine, and care collaboration. The company's IUGO health technology platform is a hardware and software solution that allows complex patients to receive high-quality care in the home, improving health outcomes, enhancing the quality of life for patients and families and reducing the cost of care delivery.
10GF Score

Get the complete analysis for RQHTF

3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.01
Price